Neu5Ac alpha(2-3)Gal beta MP Glycoside>95.0%(HPLC)10mg

4-oxo-6-(trifluoromethyl)-1,4-dihydropyridine-3-carboxylic acid, 98%, 250mg

Ethyl 5-bromo-2-chloroisonicotinate, 95.0%, 1g

2-Fluoro-2-(4-fluorophenyl)acetic acid, 95%, 500mg

Buste per campioni ROTILABO® con area di etichettatura, 200 mm, Altezza, 300 mm, 100 Pezzo(i)

Benzyl 4-(hydroxymethyl)benzylcarbamate, 95%, 500mg

(S)-4-(2-CHLORO-6-(IODOMETHYL)PYRIMIDIN-4-YL)-3-METHYLMORPHOLINE, 95.0%, 500mg

1-Phenylamino-cyclohexanecarboxylic acid, 95.0%, 1g

3,5-Di(1H-imidazol-1-yl)benzoic acid, 98%, 250mg

IMIDAZO[4,5,1-JK][1,4]BENZODIAZEPIN-7(4H)-ONE, 2-[4-[(DIMETHYLAMINO)METHYL]PHENYL]-5,6-DIHYDRO-, 95.0%, 50mg

(R)-4,4-difluoropyrrolidine-2-carboxamide hydrochloride, 98%, 100mg

tert-Butyl 3-(hydroxymethyl)-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-7-carboxylate, 95+%, 2g

5-NITROTOLUENE-2-SULPHONYL CHLORIDE, 95.0%, 250mg